|
Stock Analysis PRO New!
|
|
| Risk Assessment |
|
| Trading Strategy |
|
Editas Medicine, Inc stock upgraded to Hold/Accumulate
(Updated on Nov 17, 2025)
The Editas Medicine, Inc stock price fell by -0.769% on the last day (Monday, 17th Nov 2025) from $2.60 to $2.58. During the last trading day the stock fluctuated 6.79% from a day low at $2.51 to a day high of $2.68. The price has fallen in 5 of the last 10 days and is down by -15.69% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -538 thousand shares and in total, 1 million shares were bought and sold for approximately $3.17 million.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.51 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 12.00% during the next 3 months and, with a 90% probability hold a price between $2.82 and $4.88 at the end of this 3-month period.
EDIT Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, November 07, 2025, and so far it has risen 4.45%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Editas Medicine, Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.58 and $3.35. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Editas Medicine, Inc stock
Editas Medicine, Inc finds support from accumulated volume at $2.54 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.170 between high and low, or 6.79%. For the last week, the stock has had daily average volatility of 8.35%.
Our recommended stop-loss: $2.45 (-5.21%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 6 days ago.)
Trading Expectations (EDIT) For The Upcoming Trading Day Of Tuesday 18th
For the upcoming trading day on Tuesday, 18th we expect Editas Medicine, Inc to open at $2.59, and during the day (based on 14 day Average True Range), to move between $2.45 and $2.71, which gives a possible trading interval of +/-$0.268 (+/-10.97%) up or down from last closing price. If Editas Medicine, Inc takes out the full calculated possible swing range there will be an estimated 10.97% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $2.54 (1.55%) than the resistance at $2.83 (9.69%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Editas Medicine, Inc stock A Buy?
Editas Medicine, Inc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.
Current score:
-0.348
Hold/Accumulate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on November 18, 2025 - $2.59 ( 0.258%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
EDIT Performance
Trading levels for EDIT
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.76 | 6.85% |
| R2 | 2.69 | 4.33% |
| R1 | 2.65 | 2.78% |
| Price | 2.58 | |
| S1 | 2.52 | -2.26% |
| S2 | 2.48 | -3.81% |
| S3 | 2.42 | -6.33% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.08 | 19.38% |
| R2 | 3.00 | 16.28% |
| R1 | 2.83 | 9.69% |
| Price | 2.58 | |
| S1 | 2.54 | -1.55% |
| S2 | 2.52 | -2.33% |
| S3 | 2.47 | -4.26% |
FAQ
Click here for our free guide on how to buy Editas Medicine, Inc Stock.
Buy EDIT